These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 541259)

  • 1. Synthesis and properties of the 6'-C-alkyl derivatives of 3',4'-dideoxykanamycin B.
    Umezawa H; Ikeda D; Miyasaka T; Kondo S
    J Antibiot (Tokyo); 1979 Dec; 32(12):1360-3. PubMed ID: 541259
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of 1-N-acyl derivatives of 3', 4'-dideoxy-6'-N-methyl-kanamycin B and their antibacterial activities.
    Umezawa H; Iinuma K; Konda S; Hamada M; Maeda K
    J Antibiot (Tokyo); 1975 Apr; 28(4):340-3. PubMed ID: 1150536
    [No Abstract]   [Full Text] [Related]  

  • 3. Industrial chemical synthesis of dideoxykanamycin B.
    Fukatsu S
    Jpn J Antibiot; 1979 Dec; 32 Suppl():S178-86. PubMed ID: 398901
    [No Abstract]   [Full Text] [Related]  

  • 4. A synthesis of 3',4'-dideoxykanamycin B.
    Miyake T; Tsuchiya T; Umezawa S; Umezawa H
    Carbohydr Res; 1976 Jul; 49():141-51. PubMed ID: 963688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus.
    Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 1995 Jun; 35(6):865-8. PubMed ID: 7559197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 6'-amidine derivatives of amikacin and dibekacin.
    Iwasawa H; Ikeda D; Kondo S; Umezawa H
    J Antibiot (Tokyo); 1984 Apr; 37(4):428-30. PubMed ID: 6547135
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of dibekacin (3',4'-dideoxykanamycin B) from D-glucosamine and D-glucose.
    Yoshikawa M; Torihara M; Nakae T; Cha BC; Kitagawa I
    Chem Pharm Bull (Tokyo); 1987 May; 35(5):2136-9. PubMed ID: 3664822
    [No Abstract]   [Full Text] [Related]  

  • 8. Activity of dibekacin compared with other aminoglycoside antibiotics.
    Daschner F; Langmaack H
    J Antimicrob Chemother; 1978 May; 4(3):286-7. PubMed ID: 670124
    [No Abstract]   [Full Text] [Related]  

  • 9. [Discovery of dibekacin and its chemical aspects].
    Umezawa H
    Nouv Presse Med; 1982 Nov; 11(46):3379-84. PubMed ID: 7155844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of in vitro antimicrobial activity and human pharmacokinetics of dibekacin and tobramycin.
    Verbist L; Tjandramaga TB; Mullie A; Van Hecken A; Verbesselt R; De Schepper PJ
    Acta Clin Belg; 1982; 37(3):148-57. PubMed ID: 7124274
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M; Brun Y; Forey F; Fleurette J
    Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of dibekacin-induced nephrotoxicity in the rat by the formation of N-alkylsulfonate derivatives.
    Kitasato I; Niizato T; Watanabe T; Inouye S
    Drugs Exp Clin Res; 1989; 15(6-7):239-47. PubMed ID: 2591296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antibacterial activity of 1-N-[(S)-ω-amino-2-hydroxyalkyl] derivatives of dibekacin, 5-deoxydibekacin, 3'-deoxykanamycin A and gentamicin B.
    Umemura E; Sakamoto Y; Takahashi Y; Miyake T
    J Antibiot (Tokyo); 2015 Jun; 68(6):421-3. PubMed ID: 25712399
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibacterial activity of dibekacin against gentamicin-resistant organisms.
    Hamada M; Homma Y; Tamamura T; Kondo S
    Jpn J Antibiot; 1977 Feb; 30(2):203-5. PubMed ID: 853578
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
    Schassan HH; Witt U
    Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro antibacterial activity of dibekacin on staphylococci, streptococci and aerobic Gram negative bacilli].
    Deforges L; Van Thoi J; Le Soussy CJ; Duval J
    Nouv Presse Med; 1982 Nov; 11(46):3385-90. PubMed ID: 7155845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of dideoxykanamycin B on muscle relaxation].
    Takahashi S
    Masui; 1984 May; 33(5):485-92. PubMed ID: 6471370
    [No Abstract]   [Full Text] [Related]  

  • 18. Action mechanism of 3',4'-dideoxykanamycin B (DKB) on Klebsiella pneumoniae.
    Oizumi K; Ariji F; Kumano N; Oka S; Konno K
    Sci Rep Res Inst Tohoku Univ Med; 1974 Dec; 21(3-4):47-53. PubMed ID: 4619497
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibacterial activity and ototoxicity in guinea pigs, and nephrotoxicity in rats of arbekacin.
    Kurebe M; Yokota M; Niizato T; Kai F; Yoshida T; Okamoto R; Mitsuhashi S
    Arzneimittelforschung; 1986 Oct; 36(10):1511-7. PubMed ID: 3814212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On sensitivity test of dibekacin by the disc method (author's transl)].
    Kanazawa Y; Kuramata T
    Jpn J Antibiot; 1975 Oct; 28(5):691-6. PubMed ID: 240956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.